Processa Pharmaceuticals (PCSA) Other financing activities (2018 - 2021)
Processa Pharmaceuticals' (PCSA) quarterly Other financing activities came in at -$27980.0 in Q3 2021, up 92.15% YoY from -$14561.6 in Q3 2020, and down 100.28% on a QoQ basis from $9.9 million in Q1 2021.
Processa Pharmaceuticals (PCSA) Other financing activities (2018 - 2021) Analysis & Trends
Processa Pharmaceuticals (PCSA) has 3 years of Other financing activities data on file, last reported at -$27980.0 in Q3 2021.
- Quarterly Other financing activities rose 92.15% year-over-year to -$27980.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $9.5 million (up 2428.92% YoY) and the FY2018 annual result came in at -$168457.0, down 174.0% from the prior year.
- Other financing activities slipped to -$27980.0 in Q3 2021, from $9.9 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $9.9 million in Q1 2021 to a low of -$356416.0 in Q3 2020.
- A 3-year average of $2.4 million and a median of -$39549.0 in 2018 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 92.15% in 2021, down 92.15% in 2021.
- Tracing PCSA's Other financing activities over 3 years: stood at -$51118.0 in 2018, then slumped by 597.24% to -$356416.0 in 2020, then surged by 92.15% to -$27980.0 in 2021.
- The last three Other financing activities figures came in at -$27980.0 (Q3 2021), $9.9 million (Q1 2021), and -$356416.0 (Q3 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Processa Pharmaceuticals | 5.93 Mn | 5.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -27,980.00 |
| Sep 30, 2021 | -27,980.00 |
| Mar 31, 2021 | 9.88 Mn |
| Mar 31, 2021 | 9.88 Mn |
| Sep 30, 2020 | -356,416.00 |
| Sep 30, 2020 | -356,416.00 |
| Dec 31, 2018 | -51,118.00 |
| Dec 31, 2018 | -51,118.00 |